Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Patients aged <65 years with peripheral T-cell lymphoma (PTCL) are treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Although the addition of etoposide (CHOEP) and consolidation with autologous stem cell transplantation (ASCT) are preferred in some countries, randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brink, Mirian, Meeuwes, Frederik O., van der Poel, Marjolein W. M., Kersten, Marie José, Wondergem, Mariëlle, Mutsaers, Pim G. N. J., Böhmer, Lara H., Woei-A-Jin, F. J. Sherida H., Visser, Otto, Oostvogels, Rimke, Jansen, Patty M., Plattel, Wouter, Huls, Gerwin A., Vermaat, Joost S. P., Nijland, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437712/
https://www.ncbi.nlm.nih.gov/pubmed/35544601
http://dx.doi.org/10.1182/blood.2021015114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437712/
https://www.ncbi.nlm.nih.gov/pubmed/35544601
http://dx.doi.org/10.1182/blood.2021015114

Ejemplares similares